Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women
EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
July 31, 2013
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Conditions
Obesity
Interventions
DRUG
Celebrex
200 mg PO BID
Trial Locations (1)
10065
The Rockefeller University, New York
All Listed Sponsors
lead
Rockefeller University
OTHER
NCT01901679 - Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women | Biotech Hunter | Biotech Hunter